John Moroney to Colorectal Neoplasms
This is a "connection" page, showing publications John Moroney has written about Colorectal Neoplasms.
Connection Strength
0.250
-
Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity. Clin Cancer Res. 2012 Oct 15; 18(20):5796-805.
Score: 0.250